Genprex Signs Exclusive License Agreement with NYU Langone for Mesothelioma Treatment
April 28, 2025
Additional Gene Therapy Technology Expands Genprex’s Portfolio of Oncology Licenses Genprex, Inc. a clinical-stage gene therapy company focused on developing life-changing therapies for patients with